APA

Eremina N. V., Kazey V. I., Mishugin S. V., Leonenkov R. V., Pushkar D. Y., Mett V. L. & Gudkov A. V. (2020). First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients. : Oncotarget.

Chicago

Eremina Natalia V, Kazey Vasily I, Mishugin Sergey V, Leonenkov Roman V, Pushkar Dmitry Y, Mett Vadim L and Gudkov Andrei V. 2020. First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients. : Oncotarget.

Harvard

Eremina N. V., Kazey V. I., Mishugin S. V., Leonenkov R. V., Pushkar D. Y., Mett V. L. and Gudkov A. V. (2020). First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients. : Oncotarget.

MLA

Eremina Natalia V, Kazey Vasily I, Mishugin Sergey V, Leonenkov Roman V, Pushkar Dmitry Y, Mett Vadim L and Gudkov Andrei V. First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients. : Oncotarget. 2020.